Opsona Therapeutics

Opsona Therapeutics

Opsona Therapeutics is a drug development company specialising in the human immune system and new drugs and vaccines to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases.[1][2][3]

Based in Ireland, Opsona is a spin-out from Trinity College Dublin (TCD).[4] Ireland is ranked highly in the world in immunology research, and TCD has been at the forefront of the field.[5]

Opsona's research is primarily focused on the role of Toll-like receptors (TLRs) and TLR signalling in human innate immunity. The company was founded in 2004 by three immunologists:

Opsona's main investors are international and life-science focused:

References

  1. ↑ Article in the Irish Times
  2. ↑ Sunday Business Post article
  3. ↑ BusinessWeek company profile
  4. ↑ Article in the Irish Times
  5. ↑ Times Higher Educational Supplement - QS World University Rankings 2007
  6. ↑ Article in the Irish Examiner
  7. ↑ Article on the Trinity College Dublin website
  8. ↑ Article on the Trinity College Dublin website
  9. ↑ Article on Fierce Biotech
  10. ↑ PR Newswire article